View Older Stories View More Recent Stories

May 15, 2026 04:41PM Form SCHEDULE 13G/A OKYO Pharma Ltd Filed by: Point72 Asset Management, L.P.
May 15, 2026 04:41PM Form SCHEDULE 13G/A Q32 Bio Inc. Filed by: Point72 Asset Management, L.P.
May 15, 2026 04:40PM Form SCHEDULE 13G/A PRECIGEN, INC. Filed by: Point72 Asset Management, L.P.
May 15, 2026 04:38PM Form SCHEDULE 13G/A Korro Bio, Inc. Filed by: Point72 Asset Management, L.P.
May 15, 2026 04:35PM Form SCHEDULE 13G/A Forte Biosciences, Inc. Filed by: Point72 Asset Management, L.P.
May 15, 2026 04:35PM Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: Point72 Asset Management, L.P.
May 15, 2026 04:34PM Form SCHEDULE 13G/A PALISADE BIO, INC. Filed by: Point72 Asset Management, L.P.
May 15, 2026 04:34PM Form SCHEDULE 13G/A Dianthus Therapeutics, Filed by: Point72 Asset Management, L.P.
May 15, 2026 04:33PM Form SCHEDULE 13G/A Edesa Biotech, Inc. Filed by: Point72 Asset Management, L.P.
May 15, 2026 04:33PM Form SCHEDULE 13G/A Design Therapeutics, Filed by: Point72 Asset Management, L.P.
May 15, 2026 04:33PM Form SCHEDULE 13G/A CYBIN INC. Filed by: Point72 Asset Management, L.P.
May 15, 2026 04:32PM Form SCHEDULE 13G/A Invivyd, Inc. Filed by: Point72 Asset Management, L.P.
May 15, 2026 04:32PM Form SCHEDULE 13G/A KalVista Pharmaceuticals Filed by: Point72 Asset Management, L.P.
May 15, 2026 04:31PM Form SCHEDULE 13G/A Xilio Therapeutics, Inc. Filed by: Point72 Asset Management, L.P.
May 15, 2026 04:30PM Form SCHEDULE 13G/A Tonix Pharmaceuticals Filed by: Point72 Asset Management, L.P.
May 15, 2026 04:30PM Form SCHEDULE 13G/A Relay Therapeutics, Inc. Filed by: Point72 Asset Management, L.P.
May 15, 2026 04:30PM Form SCHEDULE 13G/A ANAPTYSBIO, INC Filed by: Point72 Asset Management, L.P.
May 15, 2026 04:29PM Form SCHEDULE 13G/A Ovid Therapeutics Inc. Filed by: Point72 Asset Management, L.P.
May 15, 2026 04:29PM Form SCHEDULE 13G/A Immunome Inc. Filed by: Point72 Asset Management, L.P.
May 15, 2026 04:29PM Form SCHEDULE 13G/A Damora Therapeutics, Filed by: Point72 Asset Management, L.P.
May 15, 2026 04:29PM Form SCHEDULE 13G/A C4 Therapeutics, Inc. Filed by: Point72 Asset Management, L.P.
May 15, 2026 04:27PM Form SCHEDULE 13G/A iBio, Inc. Filed by: Point72 Asset Management, L.P.
May 15, 2026 04:27PM Form SCHEDULE 13G/A Century Therapeutics, Filed by: Point72 Asset Management, L.P.
May 15, 2026 04:26PM Form SCHEDULE 13G/A Syndax Pharmaceuticals Filed by: Point72 Asset Management, L.P.
May 15, 2026 04:26PM Form SCHEDULE 13G/A PALATIN TECHNOLOGIES Filed by: Point72 Asset Management, L.P.
May 15, 2026 04:26PM Form SCHEDULE 13G/A Oric Pharmaceuticals, Filed by: Point72 Asset Management, L.P.
May 15, 2026 04:26PM Form 13F-HR Point72 Asset Management For: Mar 31
May 15, 2026 04:24PM Form SCHEDULE 13G/A Black Rock Coffee Bar, Filed by: Point72 Asset Management, L.P.
May 15, 2026 04:24PM Form SCHEDULE 13G/A Praxis Precision Medicin Filed by: Point72 Asset Management, L.P.
May 15, 2026 04:21PM Form SCHEDULE 13G/A Lionsgate Studios Corp. Filed by: Point72 Asset Management, L.P.
May 15, 2026 04:20PM Form SCHEDULE 13G/A Corvus Pharmaceuticals, Filed by: Point72 Asset Management, L.P.
May 15, 2026 04:20PM Form SCHEDULE 13G/A ANGIODYNAMICS INC Filed by: Point72 Asset Management, L.P.
May 15, 2026 04:18PM Form SCHEDULE 13G/A Alto Neuroscience, Inc. Filed by: Point72 Asset Management, L.P.
May 12, 2026 04:11PM Form SCHEDULE 13G STAAR SURGICAL CO Filed by: Point72 Asset Management, L.P.
May 8, 2026 04:11PM Form SCHEDULE 13G Atara Biotherapeutics, Filed by: Point72 Asset Management, L.P.
May 1, 2026 04:11PM Form SCHEDULE 13G SUTRO BIOPHARMA, INC. Filed by: Point72 Asset Management, L.P.
Apr 29, 2026 05:32PM Form SCHEDULE 13G Janux Therapeutics, Inc. Filed by: Point72 Asset Management, L.P.
Apr 29, 2026 05:31PM Form SCHEDULE 13G Janux Therapeutics, Inc. Filed by: Point72 Asset Management, L.P.
Apr 23, 2026 06:55PM Form SCHEDULE 13G Surrozen, Inc./DE Filed by: Point72 Asset Management, L.P.
Apr 16, 2026 04:10PM Form SCHEDULE 13G CytomX Therapeutics, Filed by: Point72 Asset Management, L.P.
Apr 6, 2026 04:26PM Form SCHEDULE 13G HMH Holding Inc Filed by: Point72 Asset Management, L.P.
Apr 2, 2026 04:11PM Form SCHEDULE 13G Kodiak Sciences Inc. Filed by: Point72 Asset Management, L.P.
Apr 1, 2026 05:32PM Form SCHEDULE 13G Vera Therapeutics, Inc. Filed by: Point72 Asset Management, L.P.
Mar 11, 2026 05:25PM Form SCHEDULE 13G Korro Bio, Inc. Filed by: Point72 Asset Management, L.P.
Mar 10, 2026 06:42PM Form SCHEDULE 13G/A Celldex Therapeutics, Filed by: Point72 Asset Management, L.P.
Mar 3, 2026 04:29PM Form SCHEDULE 13G Edesa Biotech, Inc. Filed by: Point72 Asset Management, L.P.
Feb 27, 2026 08:30AM reAlpha Tech appoints Thomas Kutzman as chief financial officer
Feb 23, 2026 06:10PM Form SCHEDULE 13G Beta Bionics, Inc. Filed by: Point72 Asset Management, L.P.
Feb 19, 2026 04:59PM Form SCHEDULE 13G Q32 Bio Inc. Filed by: Point72 Asset Management, L.P.
Feb 18, 2026 05:42PM Form SCHEDULE 13G OKYO Pharma Ltd Filed by: Point72 Asset Management, L.P.
View More Recent Stories View Older Stories